Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
09/02/14 Tetraphase Pharmaceuticals (TTPH) Eravacycline for Urinary Tract and Reproductive Tract Infections (Antibacterial) Subscribers Only Subscribers Only     Subscribers Only
09/02/14 Teva (TEVA) Cinquil for Asthma Subscribers Only Subscribers Only     Subscribers Only
09/02/14 Hatchtech Pty Ltd Xeglyze for Anti-parasitic and Anti-protozoal Subscribers Only Subscribers Only     Subscribers Only
09/02/14 Ampio (AMPE) Ampion for Osteoarthritis Subscribers Only Subscribers Only     Subscribers Only
09/02/14 Actavis (ACT) MuDelta for Irritable Bowel Syndrome (IBS) Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
Now - 09/03/14 Subscribers Only Subscribers Only Company - Earnings Announcement
09/03/14 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
09/03/14 Subscribers Only Subscribers Only Company - Analyst/R&D Update
Now - 09/04/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 09/04/14 Subscribers Only Subscribers Only Trial Data - Other